In order to modernise recognition for physiotherapy researchers, the Australian College of Physiotherapists is launching the specialist research physiotherapy pathway. 

Replacing the longstanding original contribution pathway, the new framework will reflect a more contemporary, comprehensive view of research excellence—one that is better aligned with the realities of clinical and academic life. 

Behind the scenes, the Research Pathway Working Group, including Professor Gavin Williams FACP, Professor Cathie Sherrington FACP and Associate Professor Wendy Bower FACP, has spent the past year developing the pathway and designing a pilot to test it.

Their goal is to align the College’s fellowship recognition with the actual work of today’s physiotherapy researchers. 

‘The previous model required three first author papers and a monograph explaining how those works contributed to physiotherapy practice but it didn’t fully reflect what being a research leader involves anymore. 

It was time for a rethink,’ says Gavin, a world leading neurological rehabilitation expert and member of the College’s Fellowship Pathways Standing Committee. 

The working group recognised the need for a more holistic and transparent pathway that would reflect the diverse ways physiotherapy researchers contribute to the profession and would align with the physiotherapy competence framework at Milestone 4 (Expert). 

The new pathway replaces thesis-style assessment with a clear, evidence-informed framework for evaluating a researcher’s contributions. 

Applicants are assessed not just on publications, but on grant leadership, peer reviewing, ethics committee involvement, conference presentations and other indicators of impact, explains Gavin. 

‘We’ve aligned assessment to national benchmarks like NHMRC Investigator Grants and academic promotion criteria. 

It’s about acknowledging the many ways research physiotherapists advance the field—far beyond what can be measured by publication lists alone.’ 

The specialist research physiotherapist pathway has just commenced its pilot phase, which is anticipated to run for six months. 

It has been designed to stress-test both the pathway and its assessment approach. 

Candidates were deliberately selected to reflect a range of research experience and were not just stand-out applicants. 

An important aspect of the pilot is to evaluate the assessment approach and include provisional assessors who haven’t been involved in the development of the pathway.

‘Consistency in evaluation is just as important as clarity in the criteria. That includes seeing how the assessors handle different profiles and borderline applications.’ 

The aim is to ensure that both the process and the assessors applying it can fairly and reliably evaluate diverse research careers. 

The pilot will generate feedback to guide final refinements before the pathway is launched to APA members in 2026. 

Interest has already exceeded available pilot places—a sign, Gavin says, of enthusiasm about the pathway’s relevance and potential to increase the number of specialist research physiotherapists in Australia. 

For many researchers, the pathway will offer a clearer, more attainable route to recognition—one that mirrors the collaborative, multidimensional nature of their work. 

‘We’re looking at any physiotherapist with research as part of their role. 

We’re especially targeting early- to mid-career researchers who are five to 10 years post- PhD, leading projects and applying for grants in their own right.’ 

The pathway is expected to take around three months from application to outcome. Compared to the original contribution pathway, it’s more transparent and efficient. Candidates map their achievements to defined criteria. 

Assessors evaluate based on evidence, not lengthy manuscripts. But more than speed or simplicity, the fellowship carries symbolic weight, says Gavin. ‘It’s the highest recognition a researcher can receive from the College. 

It acknowledges a sustained, meaningful contribution to physiotherapy. It brings visibility to the research pathway, the same way the clinical pathway has for years. 

That kind of visibility matters, not just for the individual but for our profession as a whole.’ 

Gavin knows the difference that recognition can make. 

He became a Fellow by Original Contribution in 2011; it was a milestone that helped solidify his identity as a clinical researcher. 

At the time, he was already blending clinical work with academic research at Epworth HealthCare and the University of Melbourne. 

‘I wanted to be a clinical researcher. Getting a fellowship was a way to mark that, to show my contribution and have it formally recognised.’ 

His contribution to the profession began with observing a problem: many patients with neurological injuries were leaving rehabilitation unable to run, even when they had the capacity to regain that ability. 

‘I developed a program to teach advanced gait and running skills.’ 

That program became the basis for his PhD in 2005, which produced the High-Level Mobility Assessment Tool. 

The tool is now widely used to assess people with traumatic brain injury across Australia and internationally. 

His research laid the foundation for a career that has spanned clinical innovation, academic leadership and international collaboration. 

Professor Gavin Williams FACP

From there, Gavin’s research career accelerated. He has published more than 180 peer-reviewed papers, contributed to the classification system for Paralympic athletics and built a team of clinician-researchers focused on neurological rehabilitation. 

His joint appointment at Epworth and the University of Melbourne—part clinical, part research—reflects his belief in the power of clinician-researchers to shape real-world care. 

Yet Gavin is quick to point out that research excellence is not defined by publication counts alone. 

‘Grants, collaborations, peer review—all of those things matter. 

That’s why the new pathway adopts a more expansive lens, one that mirrors the collaborative, multifaceted nature of research today.’ 

Building the new pathway was no small task. 

The working group, all senior academics with extensive experience and active involvement in national funding, academic review processes, university promotion and APA governance, aimed to produce a robust, credible and repeatable framework. 

They also recruited recent fellows to serve as assessors, helping to ensure consistent standards. ‘We wanted assessors who understood both content and context. 

People who could apply the criteria with judgement, not just tick boxes.’ 

Over time, Gavin hopes that successful candidates will become contact points for others considering the pathway. 

‘We don’t want people having to call APA staff to understand what’s involved. It’s better to talk to someone who’s been through the pathway, who can explain how it works and why it matters.’ 

For Gavin, the fellowship has delivered both professional satisfaction and personal support. 

‘Most of my mates who are fellows came through the clinical pathway. But there’s a strong peer network across both routes. 

It’s not just about titles; it’s about connecting with people who share your priorities and values.’ 

He believes that sense of shared purpose will only grow as more researchers take up the opportunity. 

‘This pathway shouldn’t be the exception; it should be the standard. If you’ve got the academic CV and you’ve made the contribution, why wouldn’t you apply? 

This is how we recognise excellence in our profession.’ 

And for those unsure about where they stand or how to begin, Gavin has one simple message: reach out. 

‘Talk to a specialist research physiotherapist fellow. Ask questions. Learn what’s involved. This is about making the pathway accessible and meaningful and we’ve built it that way on purpose.’ 

As the pilot continues and feedback is gathered, Gavin says the vision is clear: a pathway that fairly and rigorously recognises research leaders while encouraging more physiotherapists to take that path. 

‘It’s more than just a credential. It’s a statement of value for researchers, for clinicians and for the future of physiotherapy.’